Daraxonrasib FDA approval date

The FDA approved Daraxonrasib on 26 Aug 2026.

FDA approval date
26 Aug 2026

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid TumorsNCT07397338RVMDPhase 1, Phase 2Recruiting2029-05Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-08-26DayDaraxonrasibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220910", "applicant_as_listed_by_fda": "REVOLUTION MEDICINES", "brand_names": ["RASONQUE"], "active_ingredients": ["DARAXONRASIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260826", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 16 Nov 2026 · Evidence last checked: 16 Nov 2026